Skip Nav Destination
Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer—Response
Clin Cancer Res (2014) 20 (8): 2237.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses
- Flurina Boehi
- Patrick Manetsch
- Michael O. Hottiger
Cell Discovery (2021) 7 (1)
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
- Liying Ma
- Xing Bian
- Wenchu Lin
Journal of Experimental & Clinical Cancer Research (2020) 39 (1)
Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumors
- Adel Alblihy
- Katia A. Mesquita
- Maaz T. Sadiq
- Srinivasan Madhusudan
Expert Review of Precision Medicine and Drug Development (2019) 4 (1): 11.